Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Juliane Süptitz"'
Autor:
Svenja Wagener-Ryczek, Carina Heydt, Juliane Süptitz, Sebastian Michels, Markus Falk, Christina Alidousty, Jana Fassunke, Michaela Angelika Ihle, Markus Tiemann, Lukas Heukamp, Jürgen Wolf, Reinhard Büttner, Sabine Merkelbach-Bruse
Publikováno v:
BMC Cancer, Vol 20, Iss 1, Pp 1-11 (2020)
Abstract Background Over the past years, EGFR tyrosine kinase inhibitors (TKI) revolutionized treatment response. 1st-generation (reversible) EGFR TKI and later the 2nd –generation irreversible EGFR TKI Afatinib were aimed to improve treatment resp
Externí odkaz:
https://doaj.org/article/f7936ba47ab04f9d9e1b464f58d1640a
Autor:
Markus Falk, Christina Alidousty, Jürgen Wolf, Markus Tiemann, Sabine Merkelbach-Bruse, Sebastian Michels, Carina Heydt, Svenja Wagener-Ryczek, Lukas C. Heukamp, Juliane Süptitz, Reinhard Büttner, Michaela Angelika Ihle, Jana Fassunke
Publikováno v:
BMC Cancer, Vol 20, Iss 1, Pp 1-11 (2020)
BMC Cancer
BMC Cancer
BackgroundOver the past years, EGFR tyrosine kinase inhibitors (TKI) revolutionized treatment response. 1st-generation (reversible) EGFR TKI and later the 2nd –generation irreversible EGFR TKI Afatinib were aimed to improve treatment response. Neve
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::51a6cd98c3d0a04de150cb1408e8616a
http://link.springer.com/article/10.1186/s12885-020-06920-3
http://link.springer.com/article/10.1186/s12885-020-06920-3